Aurobindo Pharma Market Cap ($10.66B USD)
Aurobindo Pharma Market Cap ($10.66B USD). As of Oct. 21, 2026, Aurobindo Pharma (AUROPHARMA) market capitalisation is ₹95909.74 Cr ($10.66B), with 60.75 Cr shares outstanding at a current price of ₹1578.80 on NSE, ranking 115 out of 5367 companies by market cap in our screener. Aurobindo Pharma operates in the Healthcare sector and is classified as a Large Cap stock. Examine AUROPHARMA quarterly trends for recent quarterly revenue, profit and EPS trends.
Market Cap History of Aurobindo Pharma (Last 10 Years)
AUROPHARMA market capitalisation from year-end NSE closing prices over the last 10 years. Compare with Aurobindo Pharma value estimation to assess whether the stock is under or overvalued.
End of Year Market Cap History — Aurobindo Pharma
AUROPHARMA year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see AUROPHARMA share price.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹95909.74 Cr
$10.66B USD
|
₹1578.80 | NSE | +33.46% |
| 2025 |
₹71865.48 Cr
$7.99B USD
|
₹1183.00 | NSE | -11.35% |
| 2024 |
₹81068.88 Cr
$9.01B USD
|
₹1334.50 | NSE | +23.11% |
| 2023 |
₹65851.38 Cr
$7.32B USD
|
₹1084.00 | NSE | +147.32% |
| 2022 |
₹26626.07 Cr
$2.96B USD
|
₹438.30 | NSE | -40.31% |
| 2021 |
₹44610.66 Cr
$4.96B USD
|
₹734.35 | NSE | -20.29% |
| 2020 |
₹55967.60 Cr
$6.22B USD
|
₹921.30 | NSE | +101.66% |
| 2019 |
₹27752.95 Cr
$3.08B USD
|
₹456.85 | NSE | -37.67% |
| 2018 |
₹44525.62 Cr
$4.95B USD
|
₹732.95 | NSE | +6.54% |
| 2017 |
₹41791.93 Cr
$4.64B USD
|
₹687.95 | NSE | +2.79% |
| 2016 |
₹40658.97 Cr
$4.52B USD
|
₹669.30 | NSE | -23.59% |
| 2015 |
₹53212.65 Cr
$5.91B USD
|
₹875.95 | NSE | +54.26% |
| 2014 |
₹34496.04 Cr
$3.83B USD
|
₹567.85 | NSE | +189.13% |
| 2013 |
₹11931.01 Cr
$1.33B USD
|
₹196.40 | NSE | +107.39% |
| 2012 |
₹5752.88 Cr
$639.21M USD
|
₹94.70 | NSE | +122.40% |
| 2011 |
₹2586.67 Cr
$287.41M USD
|
₹42.58 | NSE | -67.59% |
| 2010 |
₹7981.75 Cr
$886.86M USD
|
₹131.39 | NSE | +44.08% |
| 2009 |
₹5539.66 Cr
$615.52M USD
|
₹91.19 | NSE | +441.51% |
| 2008 |
₹1023.00 Cr
$113.67M USD
|
₹16.84 | NSE | -68.99% |
| 2007 |
₹3298.64 Cr
$366.52M USD
|
₹54.30 | NSE | -23.08% |
| 2006 |
₹4288.24 Cr
$476.47M USD
|
₹70.59 | NSE | +71.92% |
| 2005 |
₹2494.33 Cr
$277.15M USD
|
₹41.06 | NSE | +25.68% |
| 2004 |
₹1984.65 Cr
$220.52M USD
|
₹32.67 | NSE | -24.06% |
| 2003 |
₹2613.40 Cr
$290.38M USD
|
₹43.02 | NSE | - |